Cardiac biomarker | Median (IQR), | Median (IQR), | Unadjusted ORa (95% CI) | p value | Adjustedb ORa (95% CI) | Adjusteda p value |
---|---|---|---|---|---|---|
 | Group 1 | Group 2 |  |  |  |  |
Cardiac troponin I | ||||||
 Any AKI (1) vs no AKI (2) | 0.14 (0.04–0.70) | 0.03 (0.02–1.0) | 1.37 (1.16–1.62) | <0.001 | 1.20 (1.00–1.45) | 0.044 |
 Stage 3 AKI (1) vs lower stage (2) | 0.22 (0.06 –1.03) | 0.04 (0.02–0.16) | 1.33 (1.14–1.54) | <0.001 | 1.17 (0.98–1.41) | 0.085 |
 Stage 3 AKI with RRT (1) vs lower stage (2) | 0.27 (0.06–1.03) | 0.04 (0.02–0.19) | 1.27 (1.10–1.40) | 0.001 | 1.09 (0.90–1.32) | 0.376 |
Cardiac troponin T | ||||||
 Any AKI (1) vs no AKI (2) | 0.07 (0.04–0.16) | 0.02 (0.01–0.05) | 1.63 (1.32–2.01) | <0.001 | 1.36 (1.06–1.74) | 0.014 |
 Stage 3 AKI (1) vs lower stage (2) | 0.10 (0.05–0.21) | 0.03 (0.01–0.07) | 1.58 (1.28–1.96) | <0.001 | 1.40 (1.06–1.84) | 0.018 |
 Stage 3 AKI with RRT (1) vs lower stage (2) | 0.10 (0.05–0.21) | 0.03 (0.01–0.08) | 1.49 (1.21–1.83) | <0.001 | 1.27 (0.95–1.69) | 0.104 |
NT-proBNP | ||||||
 Any AKI (1) vs no AKI (2) | 8888 (2504–18685) | 1543 (239–5301) | 1.41 (1.22–1.64) | <0.001 | 1.23 (1.02–1.47) | 0.027 |
 Stage 3 AKI (1) vs lower stage (2) | 10879 (2792–19797) | 1609 (480–7055) | 1.52 (1.27–1.82) | <0.001 | 1.44 (1.14–1.82) | 0.002 |
 Stage 3 AKI with RRT (1) vs lower stage (2) | 11302 (2792–21512) | 1718 (531–7293) | 1.48 (1.22–1.78) | <0.001 | 1.40 (1.09–1.81) | 0.008 |